A phase 2 trial is investigating MTX-001, an injectable regenerative therapy, for patients with noninfected venous leg ulcers.

Please provide your email address to receive an email when new articles are posted on . Complete debridement was achieved by 63% of patients treated with EscharEx vs. 30.2% and 13.3% of comparison ...

JERUSALEM, Feb 12 (Reuters) - MediWound (MDWD.O), opens new tab, an Israeli developer of products to treat burns and wounds using non-surgical tissue repair, said on Wednesday it was starting a Phase ...

After proving acellular matrices are effective in treating diabetic foot ulcers, researchers are now eyeing the treatment as a tool for healing venous leg ulcers. Typically, VLU treatment includes ...

Chronic leg ulcers represent a significant burden on patients and healthcare systems worldwide, often characterised by persistent pain that impairs mobility, sleep and quality of life. Topical ...

Plus, how chronic venous insufficiency is diagnosed and treated, and if it's actually as benign as it's been made out to be. Anna Gragert Senior Editor, Health and Home Anna Gragert (she/her/hers) was ...

VIENNA--(BUSINESS WIRE)--On the United Nations’ International Day of Older Persons, AOP Health draws attention to the often-invisible impact that Chronic Venous Ulcer (CVU) wounds have on older people ...